Neobladder and ablative pelvic radiotherapy: still a taboo?

Author:

Bergamaschi Luca12ORCID,Gerardi Marianna Alessandra1,Zaffaroni Mattia1ORCID,Augugliaro Matteo1,Vigorito Sabrina1,Rondi Elena1,Della Vigna Paolo3,Varano Gianluca3,Fumagalli Romario Uberto4,Biffi Roberto4,Picardi Edgardo Enrico Edoardo4,Ferrari Annamaria1,Jereczek-Fossa Barbara Alicja12

Affiliation:

1. Division of Radiation Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy

2. Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy

3. Interventional Radiology Division, IEO, European Institute of Oncology IRCCS, Milan, Italy

4. Department of Digestive Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy

Abstract

The presence of a neobladder constitutes a limitation for the radiation oncologist, as there is no clear evidence about its tolerance to radiotherapy (RT). The limited literature only concerns the conventional postoperative treatment in patients with bladder cancer after cystectomy. Here we report a case of a patient with neobladder who underwent a stereotactic RT for a pelvic recurrence of disease, with response to treatment and no toxicity to the neobladder. This case represents a promising example of the chance to perform RT with ablative intent, using advanced techniques, even on lesions close to the neobladder.

Funder

Italian Ministry of Health

Data collection and analysis of Tomotherapy

Publisher

SAGE Publications

Subject

Cancer Research,Oncology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3